What is the expected relative risk of macular degeneration for lutein-treated participants versus placebo-treated participants in the
Question:
What is the expected relative risk of macular degeneration for lutein-treated participants versus placebo-treated participants in the proposed study?
Suppose for the sake of simplicity that the incidence of macular degeneration is 1% per year among people65+ years of age in the therapeutic range (≥10 mg/dL) and 2% per year among people 65+ years of age with lower levels of lutein (< 10 mg/dL).
Fantastic news! We've Found the answer you've been seeking!
Step by Step Answer:
Related Book For
Question Posted: